l 740093 has been researched along with pentagastrin in 1 studies
Studies (l 740093) | Trials (l 740093) | Recent Studies (post-2010) (l 740093) | Studies (pentagastrin) | Trials (pentagastrin) | Recent Studies (post-2010) (pentagastrin) |
---|---|---|---|---|---|
16 | 0 | 0 | 3,639 | 207 | 51 |
Protein | Taxonomy | l 740093 (IC50) | pentagastrin (IC50) |
---|---|---|---|
Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.8875 | |
Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.001 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chapman, KL; Fletcher, AE; Hargreaves, RJ; Iversen, LL; Iversen, SD; Kemp, JA; Marshall, GR; Patel, S; Ryecroft, W; Smith, AJ | 1 |
1 other study(ies) available for l 740093 and pentagastrin
Article | Year |
---|---|
Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
Topics: Animals; Benzodiazepinones; Brain; Female; Gastric Acid; Guinea Pigs; In Vitro Techniques; Male; Mice; Pentagastrin; Phenylurea Compounds; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin | 1994 |